Careers in the Molecular Diagnostics Industry
It is clear that molecular diagnostics has the very real potential to achieve many of the promises of personalized medicine, perhaps even providing a means to control escalating healthcare costs. As the field of molecular diagnostics matures and evolves, we are confident that molecular techniques will help predict disease, so that, combined with patient education, there will be earlier intervention and more emphasis on preventive medicine.
The potential of the revolutionary field of personalized molecular diagnostics is rapidly gaining wide acceptance. Biomarker testing is used more and more frequently to stratify and monitor disease, aid in treatment decisions, and identify targeted therapies for each individual patient. Tests such as Invivoscribe's FLT3 Mutation test are fulfilling the promise of personalized molecular medicine.
Molecular diagnostics is the avenue to achieve personalized medicine and Invivoscribe is the forefront of these advancements in molecular medicine.
As part of the Invivoscribe team our employees are committed to improving the quality of healthcare worldwide.